Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q1 2025 Earnings Call Transcript May 13, 2025
Allogene Therapeutics, Inc. reports earnings inline with expectations. Reported EPS is $-0.28 EPS, expectations were $-0.28.
Operator: Hello. Thank you for standing by, and welcome to Allogene Therapeutics First Quarter and 2025 Conference Call. [Operator Instructions] Please be aware that, today’s conference call is being recorded. I would like to turn the call over to Christine Cassiano, Chief Corporate...
